Tonsillectomy
ProcedureTE will be performed by dissection in the peritonsillar plane. Parts of the upper and lateral palatal mucosal arches will be incised, and an extracapsular dissection for complete tonsil excision will be performed.
NCT Number: NCT07580170
The aim is to investigate whether the tissue-preserving tonsil surgery technique is as effective as complete tonsil removal in the treatment of obstructive sleep apnea. The primary outcome measure is the change in the apnea-hypopnea index (AHI) before surgery and at 4-6, 24, and 60 months after surgery.
Trial opening soon.
Get Notified18 year–65 year
All sexes
Interventional
Not applicable
Helsinki University Hospital, Helsinki, Finland
Adult reviews suggest tonsillotomy (TT) reduces morbidity compared to tonsillectomy (TE). In pediatric populations, the effectiveness of partial tonsil surgery for sleep apnea (OSA) is well-documented. It remains unclear if TT is non-inferior to TE in adults in the treatment of OSA. This study compares TE with TT in adults using change in apnea-hypopnea index as the primary endpoint.
The hypothesis is that TT is non-inferior compared to TE in treating patients with moderate or severe OSA and grade 2 to 4 tonsil size.
Participants are blinded to the allocated intervention with an allocation ratio 1:1. Participants will be recruited from patients referred to an outpatient hospital clinic. The trial will be carried out in four tertiary hospitals in Finland.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
TE will be performed by dissection in the peritonsillar plane. Parts of the upper and lateral palatal mucosal arches will be incised, and an extracapsular dissection for complete tonsil excision will be performed.
TT will be performed by removing approximately 60 - 90% of the tonsillar tissue, leaving a rim of tonsillar tissue on the tonsillar fossae. The tonsil capsule will not be breached.
Time frame: baseline, 4-6, 24 and 60 months after surgery.
The primary outcome is changes in AHI measured with home sleep study
Time frame: Baseline and 6, 12, 24 and 60 months after surgery
Measured with Epworth Sleepiness Scale (ESS) questionnaire (patient-reported). Points 0-18, higher is worse.
Time frame: Baseline and 6, 12, 24 and 60 months after surgery
Measured with Insomnia Severity Index (ISI) questionnaire, points range 0-28, higher is worse.
Time frame: Baseline and 6, 12, 24 and 60 months after surgery
Defined according to Sher's criteria: a reduction in AHI of >50% and a total AHI of <20 after surgery
Time frame: Baseline and 6, 12, 24 and 60 months after surgery
Defined as a total AHI of <5 after surgery
Time frame: Before surgery and 4-6, 24 and 60 months after surgery
Changes in nocturnal desaturation measured with oxygen saturation (SaO2) mean, min, and SpO2 <90% (T90) and ODI3, measured with home sleep study
Contact information is provided by the study sponsor or research team.
Henrik Sjöblom, MD
CONTACT
Jaakko M Piitulainen, MD, PhD
CONTACT
Turku University Hospital
Other Gov
Multicenter, National, Randomized, Patient-Blinded, Parallel Group, Non-Inferiority Trial To Compare Tonsillotomy Versus Extracapsular Tonsillectomy in Adults With Obstructive Sleep Apnea and Tonsil Hypertrophy: The TONOS Trial.
Acronym: TONOS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02920723
Apnea, Dyssomnias
Saint-Etienne, France
View Trial DetailsNCT02463890
Apnea, Dyssomnias
Saint-Etienne, France
View Trial DetailsNCT07724938
Apnea, Dyssomnias
Boston, Massachusetts, United States
View Trial DetailsNCT07723222
Apnea, Cardiovascular Autonomic Neuropathy (CAN)
View Trial Details